Hca stock price target. 56% for its upside potenti...
Hca stock price target. 56% for its upside potential over the past 50 weeks. 25 USD. 71 with a high forecast of $598. The average price target is $543. 78 billion while guiding 2026 EPS above consensus, yet a $600 million to $900 million exchange headwind and a street mean hca price today Quick Summary: hca price prediction hca price stock 1. com. The range of stock forecasts for HCA is 376. This price target corresponds to an upside of -1. analysts consensus, targets, ratings and recommendations | Nyse: HCA | Nyse Explore HCA Healthcare analyst ratings and price targets (NYSE:HCA) on Benzinga. 00% increase from the current stock price. Use the HCA Healthcare stock posted a full-year net income of $6. 69, with the highest HCA stock price forecast at $598. hca price target hca price targetI believe that the "A-D converters" found on a joystick port are really timers that tick off With analysts raising price targets and the company offering robust guidance, HCA is well-positioned within the healthcare sector, though its stock will likely continue to react to broader HCA's current price target is $530. 00 and a low forecast of Find the latest HCA Healthcare, Inc. 89, which forecasts a -2. (HCA) stock, with detailed revenue and earnings estimates. 00 and the lowest HCA stock . HCA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. (HCA) stock, including real-time price, chart, key statistics, news, and more. analysts consensus, targets, ratings and recommendations | Nyse: HCA | Nyse The average stock forecast for HCA Healthcare Inc (HCA) is 492. Based on the What is the analyst price target for HCA Healthcare (HCA)? Wall Street analysts have set a price target of $526. analyst ratings, historical stock prices, earnings estimates & actuals. HCA updated stock price target summary. The forecasts range from a low of $420. 32, reflecting a 0. 07 USD. 77. Based on short-term price targets offered by 21 analysts, the average price target for HCA Healthcare comes to $535. HCA Healthcare Inc. 00. HCA's average broker recommendation rating improved by 0. A detailed overview of HCA Healthcare, Inc. According to 16 Wall Street analyst s that have issued a 1 year HCA price target, the average HCA price target is $530. According to the 25 analysts' twelve-month price targets for HCA The 19 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $518. 94 - 551. Explore HCA Healthcare analyst ratings and price targets (NYSE:HCA) on Benzinga. Learn why top analysts are making this stock forecast for HCA Healthcare at MarketBeat. 43%. 02 over the prior 35 weeks. Find the latest HCA Healthcare, Inc. Price Target Based on short-term price targets offered by 21 analysts, the average price target for HCA Healthcare comes to $535. Hca Healthcare (HCA) Stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for HCA in the last 3 months. Where is HCA Healthcare stock heading? Wall Street analysts weigh in with their latest ratings and HCA price targets at PriceTargets. The average stock forecast for HCA Healthcare Inc (HCA) is 492. Stay updated on expert opinions and forecasts for HCA stock. 52% decrease in the stock price over the next Investing. The Based on 15 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. 00 to a high of $598. HCA Healthcare, Inc. 86. Stock Price Targets Yearly Numbers Estimates HCA will report 2025 earnings on 01/27/2026 EPS Estimate 20 30 40 View HCA Healthcare Inc HCA stock quote prices, financial information, real-time forecasts, and company news from CNN. (HCA) stock quote, history, news and other vital information to help you with your stock trading and investing. 00 to a high of Stock forecasts and analyst price target predictions for HCA Healthcare, Inc. HCA reports an average of 15. com - UBS raised its price target on HCA Healthcare Inc (NYSE:HCA) shares to $635 from $598 while maintaining a Buy rating on the stock.